|
MechanismPf20S inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with The University of Melbourne USA Foundation
0 Patents (Medical) associated with The University of Melbourne USA Foundation
100 Deals associated with The University of Melbourne USA Foundation
100 Translational Medicine associated with The University of Melbourne USA Foundation